USPTO serial 75816008
OGS
Reviewed by CopyMark Law Group
Reg. 2535393Status 710
- Filing date
- Status date
- Registration date
- Feb 5, 2002
- Examiner
- BUSH, KAREN K
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with OGS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
oxford GlycoSciences (U.K.) Limited
Oxfordshire, OX14 3YS, GB
Other trademarks owned by oxford GlycoSciences (U.K.) Limited
oxford GlycoSciences (U.K.) Limited
Oxfordshire, OX14 3YS, GB
Other trademarks owned by oxford GlycoSciences (U.K.) Limited
oxford GlycoSciences (U.K.) Limited
Oxfordshire, OX14 3YS, GB
Other trademarks owned by oxford GlycoSciences (U.K.) Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia Clarke Weber
CYNTHIA CLARKE WEBER SUGHRUE, MION, ZINN, MACPEAK & SEAS2100 PENNSYLVANIA AVENW WASHINGTON, DC 20037UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science for scientific research, namely, chemicals for use in industry and science for analyzing proteins and for use in genomics and functional genomics, including proteomics, chemicals for use in industry and science for scientific research into proteomics programs in diseases, illnesses, disorders and conditions, including breast, prostate and primary liver cancer, central nervous system disorders, Alzheimer's, atherosclerosis and neurological disorders; chemicals for use in industry and science for diagnosis, treatment or therapy of diseases, illnesses, disorders and conditions; reagents for scientific research, namely, reagents for analyzing proteins and for use in genomics and functional genomics, including proteomics, reagents for cancer research, reagents for research into central nervous system disorders, reagents for research into Alzheimer's, reagents for research into atherosclerosis, reagents for research into neurological disorders; laboratory equipment, namely, slabs of gel used for carrying proteins for analysis | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of illnesses, infectious and non-infectious diseases, disorders and conditions; pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment of atherosclerosis, pharmaceutical preparations for the treatment of Alzheimer's, pharmaceutical preparations for the treatment of inflammation, phannaceutical preparations for the treatment of neurological disorders, pharmaceutical preparations for the treatment of glycolipid storage disorders, including Gaucher disease and Fabry disease | SECTION 8 - CANCELLED | — |
| 007 | Robotic apparatus, namely, robotic apparatus used for scientific research and chemical analysis, for analyzing proteins and for use in genomics and functional genomics, including proteomics, robotic apparatus for scientific research into proteomics programs in diseases, illnesses, disorders and conditions, including breast, prostate and primary liver cancer, central nervous system disorders, Alzheimer's, atherosclerosis and neurological disorders; laboratory robots used for handling gels in the field of genomics and bioinformatics | SECTION 8 - CANCELLED | — |
| 009 | Electronic databases of biological information recorded on a computer medium; software for use in bioinformatics and genomics, namely, for use in the processing, analyzing, storing and retrieval of complex biological information with particular reference to the human genome and human proteome; laboratory apparatus and instruments, namely, computers, image analysis computer programs, extractors and material handlers, and mass spectrometers, all used for chemical analysis, for analyzing proteins and for use in genomics and functional genomics, including proteomics; laboratory robots, namely, laboratory robots used for scientific research and chemical analysis, for analyzing proteins and for use in genomics and functional genomics, including proteomics, laboratory robots used for scientific research into proteomics programs in diseases, illnesses, disorders and conditions, including breast, prostate and primary liver cancer, central nervous system disorders, Alzheimer's, atherosclerosis and neurological disorders; laboratory robots used for handling gels in the field of genomics and bioinformatics | SECTION 8 - CANCELLED | — |
| 042 | Scientific research services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by oxford GlycoSciences (U.K.) Limited
- Other trademarks owned by oxford GlycoSciences (U.K.) Limited
- Other trademarks owned by oxford GlycoSciences (U.K.) Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named OGS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 8, 2008 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Apr 9, 2007 | CFIT | CASE FILE IN TICRS | — |
| Feb 5, 2002 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 13, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 24, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| May 29, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 13, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 13, 2001 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Jan 24, 2001 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Aug 3, 2000 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 15, 2000 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2000 | DOCK | ASSIGNED TO EXAMINER | — |